Cue Biopharma, Inc. (CUE) stock
CUENasdaqPharmaceutical PreparationsFiscal year ends December 31
$14.10−2.02 (-12.53%)
Close on Nov 16, 2026Market cap $102.43MP/E –Yield –
Cue Biopharma price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Cue Biopharma's price to book ratio was 42.2× on Nov 11, 2026, against 3.7× a year earlier. Over the last 5 years it ranged from 0.8× to 58.6×, with a median of 2.7×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 42.2× | +40.4 |
| 2025 | Dec 31, 2025 | 1.8× | −0.8 |
| 2024 | Dec 31, 2024 | 2.6× | −0.2 |
| 2023 | Dec 29, 2023 | 2.8× | +0.8 |
| 2022 | Dec 30, 2022 | 2.0× | −3.6 |
| 2021 | Dec 31, 2021 | 5.6× | +1.3 |
| 2020 | Dec 31, 2020 | 4.3× | −9.2 |
| 2019 | Dec 31, 2019 | 13.5× | +11.1 |
| 2018 | Dec 31, 2018 | 2.4× | – |
See a number that looks wrong?